Phio Pharmaceuticals Employees 2024

Phio Pharmaceuticals Aktienanalyse

What does Phio Pharmaceuticals do?

Phio Pharmaceuticals Corp is a biopharmaceutical company focused on developing therapeutic products for the treatment of cancer and infectious diseases. The company is headquartered in Marlborough, Massachusetts and was founded in 1995. Phio Pharmaceuticals Corp. (formerly RXi Pharmaceuticals Corporation) originated in Worcester, Massachusetts, when founders Craig Mello and other researchers at the University of Massachusetts Medical School discovered how RNA interference (RNAi) could be used to combat diseases. The RNAi technology aims to manipulate the DNA code in cells to block the production of proteins related to disease. This technology has the potential to revolutionize the therapeutic landscape by enabling faster, more efficient, and more precise treatments than previous approaches. Phio has developed unique technologies to selectively deliver RNAi molecules to cancer tissue. The technology utilizes a family of compounds called "self-delivering RNA" (sd-rxRNA). These molecules are capable of targeting cancer cells and destroying them from within without affecting healthy cells. Phio believes that its technology has the potential for broad applications in cancer therapy and aims to treat a variety of cancer types. Phio has also developed a technology platform called "immunostimulatory RNA" (isRNA) that aims to activate the body's immune system to recognize and attack cancer cells. When injected into cancer cells, isRNA molecules can cause the immune system to recognize and attack the cancer cells as foreign. This technology has the potential to create a new class of immunotherapeutics that combines the benefits of RNAi and immunotherapy. Phio also has products in the development phase for the treatment of infectious diseases. It has developed an siRNA program for the inhibition of hepatitis B and is currently working on the development of therapeutics against dengue fever and the Zika virus. Phio has a partnership with the Karolinska Institutet, a world-leading medical university in Stockholm, Sweden, to further develop its sd-rxRNA technology. The collaboration aims to confirm the efficacy and safety of the technology and explore potential new applications in cancer therapy and other disease areas. Phio considers its sd-rxRNA products as a potentially disruptive technology that can reduce the need for conventional chemotherapy and radiation therapies, which can have high toxicity and severe side effects in many patients. The technology has the potential to create effective therapies with minimal side effects. Overall, Phio is an emerging company with a promising technology platform that has the potential to fundamentally change the therapeutic landscape. The partnership with a leading medical university and the comprehensive development pipeline suggest that the company is on track to conduct clinical trials in the near future and possibly achieve successful market launches. Phio Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Phio Pharmaceuticals's Employee Base

Phio Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Phio Pharmaceuticals's operational capacity and future potential.

Year-to-Year Comparison

Assessing Phio Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Phio Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Phio Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Phio Pharmaceuticals Stock

How many employees does Phio Pharmaceuticals have this year?

Phio Pharmaceuticals has 11 undefined employees this year.

How many employees did Phio Pharmaceuticals have compared to the previous year?

Compared to the previous year, Phio Pharmaceuticals had 0% more employees.

What impact did the number of employees have on the company Phio Pharmaceuticals?

The number of employees has a direct impact on the efficiency and productivity of Phio Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Phio Pharmaceuticals?

The number of employees can also have an impact on investors of Phio Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Phio Pharmaceuticals affect the company?

An increase in equity of Phio Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Phio Pharmaceuticals's equity affect the company?

A reduction in equity of Phio Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Phio Pharmaceuticals?

Some factors that can influence the equity of Phio Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Phio Pharmaceuticals so important for investors?

The equity of Phio Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Phio Pharmaceuticals influence the company?

The number of employees at Phio Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Phio Pharmaceuticals evolved in recent years?

In recent years, the number of employees at Phio Pharmaceuticals has changed by 0.

How many employees does Phio Pharmaceuticals currently have?

Phio Pharmaceuticals currently has 11 undefined employees.

Why is the number of employees important for investors of Phio Pharmaceuticals?

The number of employees is important for investors of Phio Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Phio Pharmaceuticals take to change the number of employees?

To change the number of employees, Phio Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Phio Pharmaceuticals pay?

Over the past 12 months, Phio Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Phio Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Phio Pharmaceuticals?

The current dividend yield of Phio Pharmaceuticals is .

When does Phio Pharmaceuticals pay dividends?

Phio Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Phio Pharmaceuticals?

Phio Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Phio Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Phio Pharmaceuticals located?

Phio Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Phio Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Phio Pharmaceuticals from 6/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/12/2024.

When did Phio Pharmaceuticals pay the last dividend?

The last dividend was paid out on 6/12/2024.

What was the dividend of Phio Pharmaceuticals in the year 2023?

In the year 2023, Phio Pharmaceuticals distributed 0 USD as dividends.

In which currency does Phio Pharmaceuticals pay out the dividend?

The dividends of Phio Pharmaceuticals are distributed in USD.